CRL Charles River Laboratories International, Inc. Stock Quote

CRL [NYSE]

Charles River Laboratories International, Inc.

Healthcare | Diagnostics & Research | USA

Index	S&P 500	P/E	26.29	EPS (ttm)	8.62	Insider Own	0.90%	Shs Outstand	50.82M	Perf Week	2.32%
Market Cap	11.73B	Forward P/E	18.34	EPS next Y	12.35	Insider Trans	-14.06%	Shs Float	50.24M	Perf Month	4.14%
Income	443.30M	PEG	1.85	EPS next Q	2.60	Inst Own	96.40%	Short Float	1.94%	Perf Quarter	-1.19%
Sales	3.69B	P/S	3.18	EPS this Y	5.60%	Inst Trans	0.81%	Short Ratio	1.95	Perf Half Y	-32.79%
Book/sh	52.10	P/B	4.35	EPS next Y	11.64%	ROA	6.20%	Target Price	286.36	Perf Year	-44.38%
Cash/sh	3.89	P/C	58.26	EPS next 5Y	14.24%	ROE	17.40%	52W Range	203.37 - 460.21	Perf YTD	-39.88%
Dividend	-	P/FCF	34.64	EPS past 5Y	18.70%	ROI	10.20%	52W High	-50.79%	Beta	1.30
Dividend %	-	Quick Ratio	1.10	Sales past 5Y	16.10%	Gross Margin	37.40%	52W Low	11.36%	ATR	9.37
Employees	18600	Current Ratio	1.30	Sales Q/Q	6.40%	Oper. Margin	18.60%	RSI (14)	48.75	Volatility	3.56% 3.65%
Optionable	Yes	Debt/Eq	1.13	EPS Q/Q	23.70%	Profit Margin	12.00%	Rel Volume	1.44	Prev Close	226.52
Shortable	Yes	LT Debt/Eq	1.13	Earnings	Aug 03 BMO	Payout	0.00%	Avg Volume	500.43K	Price	226.47
Recom	1.70	SMA20	-1.60%	SMA50	0.22%	SMA200	-23.17%	Volume	719,166	Change	-0.02%

Aug-04-22

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$350 → $250

May-24-22

Initiated

Guggenheim

Neutral

Apr-25-22

Downgrade

Jefferies

Buy → Hold

$370 → $280

Apr-07-22

Initiated

Stephens

Overweight

$377

Feb-17-22

Upgrade

Citigroup

Neutral → Buy

$400

Feb-17-22

Reiterated

UBS

Buy

$465 → $420

Feb-17-22

Reiterated

Morgan Stanley

Overweight

$465 → $430

Feb-17-22

Reiterated

Deutsche Bank

Buy

$409 → $350

Feb-17-22

Reiterated

BofA Securities

Buy

$445 → $400

Aug-05-21

Resumed

Credit Suisse

Neutral

$385

Dec-16-20

Downgrade

Citigroup

Buy → Neutral

$270 → $250

Sep-10-20

Upgrade

Jefferies

Hold → Buy

$254

Jul-01-20

Upgrade

BofA Securities

Neutral → Buy

$192

May-13-20

Upgrade

UBS

Neutral → Buy

$177 → $200

Apr-21-20

Downgrade

Jefferies

Buy → Hold

$139

Mar-27-20

Upgrade

Morgan Stanley

Equal-Weight → Overweight

$152

Mar-02-20

Initiated

Deutsche Bank

Buy

$190

Feb-18-20

Upgrade

Wolfe Research

Peer Perform → Outperform

Jan-10-20

Upgrade

Goldman

Neutral → Buy

$143 → $179

Jan-08-20

Initiated

Wells Fargo

Overweight

$180

Aug-09-22 08:00AM	Charles River Laboratories is First CDMO in North America to Receive EMA Approval to Commercially Produce an Allogeneic Cell Therapy Drug Product Business Wire
Aug-03-22 10:27AM	Charles River (CRL) Q2 Earnings Top Estimates, 2022 View Cut Zacks -9.14%
08:15AM	Charles River Laboratories (CRL) Beats Q2 Earnings Estimates Zacks
07:00AM	Charles River Laboratories Announces Second-Quarter 2022 Results Business Wire
Aug-02-22 01:13PM	MedTech Stocks to Watch for Earnings on Aug 3 Zacks
Jul-29-22 06:43AM	If EPS Growth Is Important To You, Charles River Laboratories International (NYSE:CRL) Presents An Opportunity Simply Wall St.
Jul-28-22 10:02AM	Earnings Preview: Organon (OGN) Q2 Earnings Expected to Decline Zacks
Jul-27-22 10:02AM	Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Jul-25-22 11:33AM	Charles River (CRL) to Report Q2 Earnings: What's in Store? Zacks
Jul-11-22 11:23AM	These 2 Stocks May Be Recession-Proof Motley Fool
08:30AM	Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call Business Wire
Jul-07-22 06:15AM	Cano Health, Inc. (CANO) Stock Jumps 17.1%: Will It Continue to Soar? Zacks
Jul-05-22 12:56PM	Here's Why Investors Should Retain Charles River (CRL) Now Zacks
Jun-28-22 01:08PM	Charles River (CRL) Signs saRNA-Based Vaccine Manufacture Deal Zacks
08:55AM	Could The Market Be Wrong About Charles River Laboratories International, Inc. (NYSE:CRL) Given Its Attractive Financial Prospects? Simply Wall St.
08:00AM	Charles River Laboratories Announces Opening of U.K. Manufacturing Facility Business Wire
Jun-23-22 08:00AM	Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine Business Wire +5.13%
Jun-21-22 09:30AM	Charles River (CRL) Prospers Internationally Amid FX Headwind Zacks
Jun-14-22 11:03AM	Charles River (CRL) to Create New Gene Therapy for Hemophilia A Zacks
Jun-13-22 08:00AM	Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A Business Wire
Jun-08-22 07:33AM	Charles River Labs stock slides 6% premarket after company issues profit warning for Q2 MarketWatch
Jun-06-22 08:00AM	Charles River Laboratories to Participate in Jefferies and William Blair Conferences Business Wire
Jun-03-22 11:31AM	Why Is Charles River (CRL) Down 1.2% Since Last Earnings Report? Zacks
09:40AM	Why Charles River Laboratories (CRL) is a Top Value Stock for the Long-Term Zacks
May-26-22 10:34AM	10 Biggest Losers in Gabriel Plotkins Melvin Capital Portfolio Insider Monkey
May-25-22 03:57PM	Charles River Labs to add 500 more jobs with Ashland expansion project American City Business Journals
May-24-22 07:57AM	Charles River Laboratories International, Inc.'s (NYSE:CRL) Intrinsic Value Is Potentially 87% Above Its Share Price Simply Wall St.
May-16-22 11:47AM	Here's Why You Should Retain Charles River (CRL) Stock for Now Zacks
May-10-22 10:48AM	Charles River (CRL) DSA Arm Prospers, Currency Headwind Stays Zacks
May-04-22 11:42AM	Charles River (CRL) Q1 Earnings Top, Gross Margin Falls Zacks
08:15AM	Charles River Laboratories (CRL) Q1 Earnings and Revenues Beat Estimates Zacks
07:00AM	Charles River Laboratories Announces First-Quarter 2022 Results Business Wire
May-03-22 10:34AM	MedTech Stocks' Q1 Earnings Due on May 4: CRL, IDXX & NUVA Zacks
Apr-28-22 07:09AM	Charles River Laboratories International's (NYSE:CRL) five-year total shareholder returns outpace the underlying earnings growth Simply Wall St.
Apr-27-22 03:03PM	Charles River Laboratories (CRL) Earnings Expected to Grow: Should You Buy? Zacks
10:24AM	Charles River (CRL) to Report Q1 Earnings: What's in Store? Zacks
08:00AM	Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets Business Wire
Apr-13-22 04:30PM	Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call Business Wire
Apr-11-22 11:48AM	Charles River (CRL) Buys Explora BioLabs to Expand in CRO Space Zacks
08:54AM	Here's Why You Should Retain Charles River (CRL) Stock For Now Zacks
01:42AM	Creightons Plc (LON:CRL) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? Simply Wall St.
Apr-07-22 08:00AM	Charles River Laboratories Publishes 2021 Corporate Citizenship Report Business Wire +5.59%
Apr-06-22 08:00AM	Charles River Laboratories Acquires Explora BioLabs Business Wire
Apr-05-22 09:31AM	Heres Why You Should Buy Charles River Laboratories (CRL) Shares Insider Monkey
Mar-31-22 06:00AM	The Petri Dish: Adagio says its antibody works against omicron now American City Business Journals
Mar-28-22 11:31AM	Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy? Zacks
08:00AM	Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer Business Wire
Mar-27-22 02:18PM	Why Charles River Laboratories International, Inc. (NYSE:CRL) Could Be Worth Watching Simply Wall St.
Mar-18-22 11:30AM	Why Is Charles River (CRL) Down 3.4% Since Last Earnings Report? Zacks
Mar-16-22 02:30AM	CoDiagnostics, Inc. (CODX) Surges 13.1%: Is This an Indication of Further Gains? Zacks
Mar-10-22 05:41AM	The Petri Dish: Moderna changes tune on patents, Alloy invests in peptide startup American City Business Journals
Mar-09-22 08:48AM	Here's Why You Should Retain Charles River (CRL) Stock For Now Zacks
Feb-22-22 10:56AM	Charles River (CRL) DSA Arm Sees Growth, Cell Supply Sluggish Zacks
Feb-19-22 06:55AM	Here's Why We Think Charles River Laboratories International (NYSE:CRL) Is Well Worth Watching Simply Wall St.
Feb-17-22 08:18AM	Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now Zacks
08:16AM	Tandem Diabetes (TNDM) to Offer Insulin Delivery With Smartphone Zacks
Feb-16-22 10:48AM	Charles River (CRL) Q4 Earnings Beat Estimates, Margins Up Zacks
08:15AM	Charles River Laboratories (CRL) Tops Q4 Earnings and Revenue Estimates Zacks
07:00AM	Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results Business Wire
Feb-15-22 10:19AM	Land on 5 Winning Stocks With the Overlooked Rising P/E Trick Zacks
09:44AM	Here's Why You Should Hold on to Thermo Fisher (TMO) Stock Now Zacks
Feb-11-22 11:09AM	Charles River (CRL) to Report Q4 Earnings: What's in Store? Zacks
Feb-09-22 03:01PM	Charles River Laboratories (CRL) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Feb-08-22 08:11AM	Here's Why You Should Retain Bio-Rad (BIO) Stock for Now Zacks
Feb-07-22 07:43AM	Medtronic (MDT) Reports First Procedure in Europe With Hugo RAS Zacks
Feb-04-22 04:33PM	Were Hedge Funds Illusioned With Charles River Laboratories International Inc. (CRL)? Insider Monkey
12:45PM	Is Charles River (CRL) a Solid Growth Stock? 3 Reasons to Think " Yes " Zacks
Feb-03-22 08:00AM	Charles River Laboratories Announces Wind Contract with Repsol for European Operations Business Wire
Feb-02-22 11:45AM	Abbott's (ABT) Diabetes Arm Booms, Neuromodulation Sales Soft Zacks
Feb-01-22 08:23AM	Here's Why You Should Hold on to Tandem Diabetes (TNDM) for Now Zacks
08:00AM	Prepare For More Losses In February Unless You Own These 3 Stocks Investor's Business Daily
Jan-27-22 09:38AM	Seatown Holdings Pte. Ltd. Buys Amazon.com Inc, Air Products & Chemicals Inc, Abbott ... GuruFocus.com
08:00AM	Charles River Expands Strategic Partnership With SAMDI Tech Business Wire
Jan-26-22 09:38AM	Creative Financial Designs Inc Buys Caterpillar Inc, Inspire 100 ETF, Inspire Global Hope ETF, ... GuruFocus.com
Jan-24-22 01:38PM	Strs Ohio Buys iShares MSCI EAFE ETF, ZoomInfo Technologies Inc, Mastercard Inc, Sells Oracle ... GuruFocus.com
09:38AM	Arden Trust Co Buys iShares Core U.S. Aggregate Bond ETF, iShares MSCI EAFE ETF, Wolfspeed Inc, ... GuruFocus.com
Jan-21-22 05:38PM	Patton Fund Management, Inc. Buys Arista Networks Inc, Equifax Inc, Ford Motor Co, Sells ... GuruFocus.com
09:38AM	PFG Advisors Buys Pacer Lunt Large Cap Alternator ETF, First Trust NASDAQ Rising Dividend ... GuruFocus.com
09:38AM	New Potomac Partners, LLC Buys Simon Property Group Inc, Invesco BulletShares 2027 Corporate ... GuruFocus.com
Jan-20-22 08:30AM	Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call Business Wire
Jan-19-22 12:45PM	3 Reasons Why Charles River (CRL) Is a Great Growth Stock Zacks
09:00AM	Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions Business Wire
Jan-18-22 05:38PM	Central Bank & Trust Co Buys IQ Hedge Multi-Strategy Tracker ETF, iShares iBoxx USD High ... GuruFocus.com
Jan-11-22 07:00AM	Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan Business Wire +7.14%
Jan-06-22 08:00AM	Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Business Wire
Jan-04-22 01:38PM	Confluence Investment Management Llc Buys iShares iBonds Dec 2030 Term Corporate ETF, Gates ... GuruFocus.com
Dec-31-21 07:30AM	Is Charles River Laboratories (CRL) A Worthy Stock Investment? Insider Monkey
Dec-27-21 10:38PM	M3Sixty Funds Trust Buys Datadog Inc, Ford Motor Co, GoodRx Holdings Inc, Sells Snap Inc, ... GuruFocus.com
Dec-20-21 05:38AM	LVIP ClearBridge Franklin Select Large Cap Managed Volatility Fund Buys HubSpot Inc, Cisco ... GuruFocus.com
Dec-17-21 05:38PM	Power Momentum Index VIT Fund Buys Targa Resources Corp, Boyd Gaming Corp, Alliance Data ... GuruFocus.com
Dec-16-21 05:38PM	Franklin Custodian Funds Buys Repligen Corp, DoorDash Inc, Intellia Therapeutics Inc, Sells ... GuruFocus.com
09:38AM	VIP Health Care Portfolio Buys Thermo Fisher Scientific Inc, Royalty Pharma PLC, Charles River ... GuruFocus.com
12:38AM	VIP Strategic Income Portfolio Buys Williams-Sonoma Inc, Builders FirstSource Inc, GXO ... GuruFocus.com
Dec-15-21 09:38AM	Franklin DynaTech VIP Fund Buys Intuitive Surgical Inc, Moderna Inc, Airbnb Inc, Sells Nintendo ... GuruFocus.com
09:05AM	Here's Why You Should Retain Charles River (CRL) Stock for Now Zacks
05:18AM	Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth US$354 Based On Its Intrinsic Value? Simply Wall St.
Dec-14-21 01:38PM	Strategy Asset Managers Llc Buys Broadcom Inc, eBay Inc, Extra Space Storage Inc, Sells , Meta ... GuruFocus.com
Dec-08-21 07:38PM	Tekla World Healthcare Fund Buys Moderna Inc, Merck Inc, AstraZeneca PLC, Sells ResMed Inc, ... GuruFocus.com
07:38PM	Tekla Life Sciences Investors Buys Amgen Inc, Alkermes PLC, Novavax Inc, Sells Moderna Inc, ... GuruFocus.com
05:38PM	Moors & Cabot, Inc. Buys NVIDIA Corp, Nike Inc, Procter & Gamble Co, Sells Splunk Inc, ... GuruFocus.com

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LaPlume Joseph W	EVP, Corp Strategy & Develop	Aug 05	Sale	226.13	200	45,227	20,766	Aug 08 03:03 PM
MASSARO GEORGE	Director	May 09	Sale	230.96	178	41,110	4,677	May 11 03:52 PM
Smith David Ross	Corporate Executive VP & CFO	Mar 03	Option Exercise	136.60	8,965	1,224,594	34,784	Mar 04 04:13 PM
Smith David Ross	Corporate Executive VP & CFO	Mar 03	Sale	282.53	8,965	2,532,921	25,819	Mar 04 04:13 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 23	Option Exercise	109.34	20,296	2,219,165	235,318	Feb 25 04:20 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 23	Sale	287.83	20,296	5,841,869	215,022	Feb 25 04:20 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Feb 23	Sale	292.75	395	115,636	19,852	Feb 24 06:37 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 22	Option Exercise	144.67	17,436	2,522,466	234,228	Feb 23 04:49 PM
WALLMAN RICHARD F	Director	Feb 22	Sale	288.05	3,250	936,162	0	Feb 23 04:07 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 22	Sale	288.67	17,436	5,033,328	216,792	Feb 23 04:49 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Feb 22	Sale	290.83	396	115,170	20,562	Feb 23 04:44 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Feb 18	Option Exercise	88.05	743	65,421	22,418	Feb 23 04:44 PM
WALLMAN RICHARD F	Director	Feb 18	Sale	297.50	2,800	833,000	3,250	Feb 23 04:07 PM
WALLMAN RICHARD F	Director	Feb 18	Sale	295.00	1,150	339,250	17,679	Feb 23 04:07 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Feb 18	Sale	291.80	1,143	333,527	21,275	Feb 23 04:44 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 15	Sale	315.46	20,000	6,309,137	218,402	Feb 17 04:41 PM
Girshick Birgit	Corporate Executive VP	Sep 14	Sale	439.90	2,344	1,031,126	27,602	Sep 15 11:11 AM
Girshick Birgit	Corporate Executive VP	Sep 13	Sale	442.19	81	35,817	29,946	Sep 15 11:11 AM
MASSARO GEORGE	Director	Aug 31	Option Exercise	164.24	2,539	417,005	7,394	Sep 01 02:29 PM
MASSARO GEORGE	Director	Aug 31	Sale	442.48	2,539	1,123,457	4,855	Sep 01 02:29 PM
Creamer Victoria L	EVP & Chief People Officer	Aug 16	Option Exercise	145.34	6,917	1,005,330	13,303	Aug 17 03:01 PM
Creamer Victoria L	EVP & Chief People Officer	Aug 16	Sale	415.24	6,917	2,872,236	6,386	Aug 17 03:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience